{
  "actions": [
    {
      "acted_at": "2024-12-09",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2024-12-09",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s5459-118",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "118",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2024-12-09",
  "number": "5459",
  "official_title": "A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Biosimilars Access and Affordability Act",
  "sponsor": {
    "bioguide_id": "B001243",
    "district": null,
    "name": "Blackburn, Marsha",
    "state": "TN",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2024-12-09",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Biosimilars Access and Affordability Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Biosimilars Access and Affordability Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.",
      "type": "official"
    }
  ],
  "updated_at": "2025-08-18T16:23:02Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/s/BILLSTATUS-118s5459.xml"
}